428 related articles for article (PubMed ID: 26913536)
21. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
[TBL] [Abstract][Full Text] [Related]
22. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer.
Li W; Zhang X; Yang Y; Lin J; Zhou K; Sun R; Dang C; Diao D
Sci Rep; 2024 Jun; 14(1):12758. PubMed ID: 38830909
[TBL] [Abstract][Full Text] [Related]
24. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
[TBL] [Abstract][Full Text] [Related]
25. Circulating tumor cells in peripheral and pulmonary venous blood predict poor long-term survival in resected non-small cell lung cancer patients.
Li Y; Cheng X; Chen Z; Liu Y; Liu Z; Xu S
Sci Rep; 2017 Jul; 7(1):4971. PubMed ID: 28694485
[TBL] [Abstract][Full Text] [Related]
26. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
Chen X; Wang X; He H; Liu Z; Hu JF; Li W
PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
[TBL] [Abstract][Full Text] [Related]
27. Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas.
Dandachi N; Tiran V; Lindenmann J; Brcic L; Fink-Neuboeck N; Kashofer K; Absenger G; Bezan A; Cote RJ; Datar R; Balic M
Lung Cancer; 2017 Nov; 113():152-157. PubMed ID: 29110843
[TBL] [Abstract][Full Text] [Related]
28. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse.
Chemi F; Rothwell DG; McGranahan N; Gulati S; Abbosh C; Pearce SP; Zhou C; Wilson GA; Jamal-Hanjani M; Birkbak N; Pierce J; Kim CS; Ferdous S; Burt DJ; Slane-Tan D; Gomes F; Moore D; Shah R; Al Bakir M; Hiley C; Veeriah S; Summers Y; Crosbie P; Ward S; Mesquita B; Dynowski M; Biswas D; Tugwood J; Blackhall F; Miller C; Hackshaw A; Brady G; Swanton C; Dive C;
Nat Med; 2019 Oct; 25(10):1534-1539. PubMed ID: 31591595
[TBL] [Abstract][Full Text] [Related]
30. Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study results.
Dorsey JF; Kao GD; MacArthur KM; Ju M; Steinmetz D; Wileyto EP; Simone CB; Hahn SM
Cancer; 2015 Jan; 121(1):139-49. PubMed ID: 25241991
[TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy.
Frick MA; Feigenberg SJ; Jean-Baptiste SR; Aguarin LA; Mendes A; Chinniah C; Swisher-McClure S; Berman A; Levin W; Cengel KA; Hahn SM; Dorsey JF; Simone CB; Kao GD
Clin Cancer Res; 2020 May; 26(10):2372-2380. PubMed ID: 31969332
[TBL] [Abstract][Full Text] [Related]
32. Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival.
Tamminga M; Andree KC; van den Bos H; Hiltermann TJN; Mentink A; Spierings DCJ; Lansdorp P; Timens W; Schuuring E; Terstappen LWMM; Groen HJM
Br J Cancer; 2022 Feb; 126(3):409-418. PubMed ID: 34848855
[TBL] [Abstract][Full Text] [Related]
33. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer.
Isobe K; Hata Y; Kobayashi K; Hirota N; Sato K; Sano G; Sugino K; Sakamoto S; Takai Y; Shibuya K; Takagi K; Homma S
Anticancer Res; 2012 Aug; 32(8):3339-44. PubMed ID: 22843912
[TBL] [Abstract][Full Text] [Related]
35. Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood?
Sawabata N; Funaki S; Hyakutake T; Shintani Y; Fujiwara A; Okumura M
Surg Today; 2016 Dec; 46(12):1402-1409. PubMed ID: 26951195
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method.
Sawabata N; Okumura M; Utsumi T; Inoue M; Shiono H; Minami M; Nishida T; Sawa Y
Gen Thorac Cardiovasc Surg; 2007 May; 55(5):189-92. PubMed ID: 17554991
[TBL] [Abstract][Full Text] [Related]
39. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study.
Yamashita J; Matsuo A; Kurusu Y; Saishoji T; Hayashi N; Ogawa M
J Thorac Cardiovasc Surg; 2002 Aug; 124(2):299-305. PubMed ID: 12167790
[TBL] [Abstract][Full Text] [Related]
40. Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.
Shishido SN; Carlsson A; Nieva J; Bethel K; Hicks JB; Bazhenova L; Kuhn P
J Transl Med; 2019 Aug; 17(1):294. PubMed ID: 31462312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
